In an analysis from The Cancer Genome Atlas, lung cancer patients with high expression of EAAT3 exhibited poor survival rate compared to patients with low EAAT3 expression, thus supporting the notion that EAAT3 is important in lung tumor progression (188). Here, SLC1A1 is linked to lung cancer.